Contact Investor Relations

We are happy to answer questions on the Chr. Hansen share or any other capital market topics.

Novozymes and Chr. Hansen have joined forces to create Novonesis, a leading biosolutions partner. Working closely with our customers, we’re transforming the way the world produces, consumes and lives. 

To contact the Novonesis investor relations team, please click below: